Yahoo Web Search

Search results

  1. Jan 22, 2019 · The first settlement, approved on January 16, 2019, by U.S. District Judge Paul A. Crotty and unsealed today, requires WALGREENS to pay $209.2 million to resolve allegations that it improperly billed Medicare, Medicaid, and other federal healthcare programs for hundreds of thousands of insulin pens it knowingly dispensed to program ...

  2. Jan 22, 2019 · The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs from 2006 to 2017 for hundreds of thousands of insulin pens it ...

  3. Jan 23, 2019 · Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs over a decade, the U.S....

  4. Jan 23, 2019 · The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs from 2006 to 2017 for hundreds of thousands of insulin pens it dispensed to patients it knew did not need them.

  5. Feb 22, 2019 · In the first suit, the chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid, and other federal programs from 2006 through 2017 for hundreds of thousands of insulin pens dispensed to patients known not to need them.

  6. Jan 23, 2019 · Walgreens Boots Alliance has agreed to pay more than $269 million to settle allegations it took advantage of Medicare and Medicaid, the U.S. Department of Justice said Tuesday.

  7. People also ask

  8. Jan 24, 2019 · In one settlement, Walgreens must pay $209.2 million to resolve allegations that it knowingly billed the Medicare and Medicaid programs for hundreds of thousands of insulin pens dispensed to beneficiaries who did not need them.

  1. People also search for